<section number="58-17b-102"><effdate>5/6/2026</effdate><histories><history>Amended by Chapter <modchap sess="2026GS">362</modchap>, 2026 General Session</history><modyear>2026</modyear></histories><catchline>Definitions.</catchline><tab/>In addition to the definitions in Section <xref depth="3" refnumber="58-1-102">58-1-102</xref>, as used in this chapter:<subsection number="58-17b-102(1)">"Administering" means:<subsection number="58-17b-102(1)(a)">the direct application of a prescription drug or device, whether by injection, inhalation, ingestion, or by any other means, to the body of a human patient or research subject by another person; or</subsection><subsection number="58-17b-102(1)(b)">the placement by a veterinarian with the owner or caretaker of an animal or group of animals of a prescription drug for the purpose of injection, inhalation, ingestion, or any other means directed to the body of the animal by the owner or caretaker in accordance with written or verbal directions of the veterinarian.</subsection></subsection><subsection number="58-17b-102(2)">"Adulterated drug or device" means a drug or device considered adulterated under 21 U.S.C. Sec. 351 (2003).</subsection><subsection number="58-17b-102(3)"><subsection number="58-17b-102(3)(a)">"Analytical laboratory" means a facility in possession of prescription drugs for the purpose of analysis.</subsection><subsection number="58-17b-102(3)(b)">"Analytical laboratory" does not include a laboratory possessing prescription drugs used as standards and controls in performing drug monitoring or drug screening analysis if the prescription drugs are prediluted in a human or animal body fluid, human or animal body fluid components, organic solvents, or inorganic buffers at a concentration not exceeding one milligram per milliliter when labeled or otherwise designated as being for in vitro diagnostic use.</subsection></subsection><subsection number="58-17b-102(4)">"Animal euthanasia agency" means an agency performing euthanasia on animals by the use of prescription drugs.</subsection><subsection number="58-17b-102(5)">"Automated pharmacy systems" includes mechanical systems which perform operations or activities, other than compounding or administration, relative to the storage, packaging, dispensing, or distribution of medications, and which collect, control, and maintain all transaction information.</subsection><subsection number="58-17b-102(6)">"Beyond use date" means the date determined by a pharmacist and placed on a prescription label at the time of dispensing that indicates to the patient or caregiver a time beyond which the contents of the prescription are not recommended to be used.</subsection><subsection number="58-17b-102(7)">"Board of pharmacy" or "board" means the Utah State Board of Pharmacy created in Section <xref depth="3" refnumber="58-17b-201">58-17b-201</xref>.</subsection><subsection number="58-17b-102(8)">"Branch pharmacy" means a pharmacy or other facility in a rural or medically underserved area, used for the storage and dispensing of prescription drugs, which is dependent upon, stocked by, and supervised by a pharmacist in another licensed pharmacy designated and approved by the division as the parent pharmacy.</subsection><subsection number="58-17b-102(9)">"Centralized prescription processing" means the processing by a pharmacy of a request from another pharmacy to fill or refill a prescription drug order or to perform processing functions such as dispensing, drug utilization review, claims adjudication, refill authorizations, and therapeutic interventions.</subsection><subsection number="58-17b-102(10)">"Class A pharmacy" means a pharmacy located in Utah that is authorized as a retail pharmacy to compound or dispense a drug or dispense a device to the public under a prescription order.</subsection><subsection number="58-17b-102(11)">"Class B pharmacy":<subsection number="58-17b-102(11)(a)">means a pharmacy located in Utah:<subsection number="58-17b-102(11)(a)(i)">that is authorized to provide pharmaceutical care for patients in an institutional setting; and</subsection><subsection number="58-17b-102(11)(a)(ii)">whose primary purpose is to provide a physical environment for patients to obtain health care services; and</subsection></subsection><subsection number="58-17b-102(11)(b)"><subsection number="58-17b-102(11)(b)(i)">includes closed-door, hospital, clinic, nuclear, and branch pharmacies; and</subsection><subsection number="58-17b-102(11)(b)(ii)">pharmaceutical administration and sterile product preparation facilities.</subsection></subsection></subsection><subsection number="58-17b-102(12)">"Class C pharmacy" means a pharmacy that engages in the manufacture, production, wholesale, or distribution of drugs or devices in Utah.</subsection><subsection number="58-17b-102(13)">"Class D pharmacy" means a nonresident pharmacy.</subsection><subsection number="58-17b-102(14)">"Class E pharmacy" means all other pharmacies.</subsection><subsection number="58-17b-102(15)"><subsection number="58-17b-102(15)(a)">"Closed-door pharmacy" means a pharmacy that:<subsection number="58-17b-102(15)(a)(i)">provides pharmaceutical care to a defined and exclusive group of patients who have access to the services of the pharmacy because they are treated by or have an affiliation with a specific entity, including a health maintenance organization or an infusion company; or</subsection><subsection number="58-17b-102(15)(a)(ii)">engages exclusively in the practice of telepharmacy and does not serve walk-in retail customers.</subsection></subsection><subsection number="58-17b-102(15)(b)">"Closed-door pharmacy" does not include a hospital pharmacy, a retailer of goods to the general public, or the office of a practitioner.</subsection></subsection><subsection number="58-17b-102(16)">"Collaborative pharmacy practice" means a practice of pharmacy whereby one or more pharmacists have jointly agreed, on a voluntary basis, to work in conjunction with one or more practitioners under protocol whereby the pharmacist may perform certain pharmaceutical care functions authorized by the practitioner or practitioners under certain specified conditions or limitations.</subsection><subsection number="58-17b-102(17)">"Collaborative pharmacy practice agreement" means a written and signed agreement between one or more pharmacists and one or more practitioners that provides for collaborative pharmacy practice for the purpose of drug therapy management of patients, initiating therapy, and prevention of disease of human subjects.</subsection><subsection number="58-17b-102(18)"><subsection number="58-17b-102(18)(a)">"Compounding" means the preparation, mixing, assembling, packaging, or labeling of a limited quantity drug, sterile product, or device:<subsection number="58-17b-102(18)(a)(i)">as the result of a practitioner's prescription order or initiative based on the practitioner, patient, or pharmacist relationship in the course of professional practice;</subsection><subsection number="58-17b-102(18)(a)(ii)">for the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale or dispensing; or</subsection><subsection number="58-17b-102(18)(a)(iii)">in anticipation of prescription drug orders based on routine, regularly observed prescribing patterns.</subsection></subsection><subsection number="58-17b-102(18)(b)">"Compounding" does not include:<subsection number="58-17b-102(18)(b)(i)">the preparation of prescription drugs by a pharmacist or pharmacy intern for sale to another pharmacist or pharmaceutical facility;</subsection><subsection number="58-17b-102(18)(b)(ii)">the preparation by a pharmacist or pharmacy intern of any prescription drug in a dosage form which is regularly and commonly available from a manufacturer in quantities and strengths prescribed by a practitioner; or</subsection><subsection number="58-17b-102(18)(b)(iii)">the preparation of a prescription drug, sterile product, or device which has been withdrawn from the market for safety reasons.</subsection></subsection></subsection><subsection number="58-17b-102(19)">"Confidential information" has the same meaning as "protected health information" under the Standards for Privacy of Individually Identifiable Health Information, 45 C.F.R. Parts 160 and 164.</subsection><subsection number="58-17b-102(20)">"Controlled substance" means the same as that term is defined in Section <xref depth="3" refnumber="58-37-101">58-37-101</xref>.</subsection><subsection number="58-17b-102(21)">"Dietary supplement" has the same meaning as Public Law Title 103, Chapter 417, Sec. 3a(ff) which is incorporated by reference.</subsection><subsection number="58-17b-102(22)">"Dispense" means the interpretation, evaluation, and implementation of a prescription drug order or device or nonprescription drug or device under a lawful order of a practitioner in a suitable container appropriately labeled for subsequent administration to or use by a patient, research subject, or an animal.</subsection><subsection number="58-17b-102(23)">"Dispensing medical practitioner" means an individual who is:<subsection number="58-17b-102(23)(a)">currently licensed as:<subsection number="58-17b-102(23)(a)(i)">a physician and surgeon under Chapter 67, Utah Medical Practice Act;</subsection><subsection number="58-17b-102(23)(a)(ii)">an osteopathic physician and surgeon under Chapter 68, Utah Osteopathic Medical Practice Act;</subsection><subsection number="58-17b-102(23)(a)(iii)">a physician assistant under Chapter 70a, Utah Physician Assistant Act;</subsection><subsection number="58-17b-102(23)(a)(iv)">a nurse practitioner under Chapter 31b, Nurse Practice Act; or</subsection><subsection number="58-17b-102(23)(a)(v)">an optometrist under Chapter 16a, Utah Optometry Practice Act, if the optometrist is acting within the scope of practice for an optometrist; and</subsection></subsection><subsection number="58-17b-102(23)(b)">licensed by the division under the Pharmacy Practice Act to engage in the practice of a dispensing medical practitioner.</subsection></subsection><subsection number="58-17b-102(24)">"Dispensing medical practitioner clinic pharmacy" means a closed-door pharmacy located within a licensed dispensing medical practitioner's place of practice.</subsection><subsection number="58-17b-102(25)">"Distribute" means to deliver a drug or device other than by administering or dispensing.</subsection><subsection number="58-17b-102(26)"><subsection number="58-17b-102(26)(a)">"Drug" means:<subsection number="58-17b-102(26)(a)(i)">a substance recognized in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them, intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or animals;</subsection><subsection number="58-17b-102(26)(a)(ii)">a substance that is required by any applicable federal or state law or rule to be dispensed by prescription only or is restricted to administration by practitioners only;</subsection><subsection number="58-17b-102(26)(a)(iii)">a substance other than food intended to affect the structure or any function of the body of humans or other animals; and</subsection><subsection number="58-17b-102(26)(a)(iv)">substances intended for use as a component of any substance specified in Subsections <xref depth="4" refnumber="58-17b-102(26)(a)(i)">(26)(a)(i)</xref> through <xref depth="4" refnumber="58-17b-102(iii)">(iii)</xref>.</subsection></subsection><subsection number="58-17b-102(26)(b)">"Drug" does not include dietary supplements.</subsection></subsection><subsection number="58-17b-102(27)">"Drug regimen review" includes the following activities:<subsection number="58-17b-102(27)(a)">evaluation of the prescription drug order and patient record for:<subsection number="58-17b-102(27)(a)(i)">known allergies;</subsection><subsection number="58-17b-102(27)(a)(ii)">rational therapy-contraindications;</subsection><subsection number="58-17b-102(27)(a)(iii)">reasonable dose and route of administration; and</subsection><subsection number="58-17b-102(27)(a)(iv)">reasonable directions for use;</subsection></subsection><subsection number="58-17b-102(27)(b)">evaluation of the prescription drug order and patient record for duplication of therapy;</subsection><subsection number="58-17b-102(27)(c)">evaluation of the prescription drug order and patient record for the following interactions:<subsection number="58-17b-102(27)(c)(i)">drug-drug;</subsection><subsection number="58-17b-102(27)(c)(ii)">drug-food;</subsection><subsection number="58-17b-102(27)(c)(iii)">drug-disease; and</subsection><subsection number="58-17b-102(27)(c)(iv)">adverse drug reactions; and</subsection></subsection><subsection number="58-17b-102(27)(d)">evaluation of the prescription drug order and patient record for proper utilization, including over- or under-utilization, and optimum therapeutic outcomes.</subsection></subsection><subsection number="58-17b-102(28)">"Drug sample" means a prescription drug packaged in small quantities consistent with limited dosage therapy of the particular drug, which is marked "sample", is not intended to be sold, and is intended to be provided to practitioners for the immediate needs of patients for trial purposes or to provide the drug to the patient until a prescription can be filled by the patient.</subsection><subsection number="58-17b-102(29)">"Electronic signature" means a trusted, verifiable, and secure electronic sound, symbol, or process attached to or logically associated with a record and executed or adopted by a person with the intent to sign the record.</subsection><subsection number="58-17b-102(30)">"Electronic transmission" means transmission of information in electronic form or the transmission of the exact visual image of a document by way of electronic equipment.</subsection><subsection number="58-17b-102(31)">"Hospital pharmacy" means a pharmacy providing pharmaceutical care to inpatients of a general acute hospital or specialty hospital licensed by the Department of Health and Human Services under Title 26B, Chapter 2, Part 2, Health Care Facility Licensing and Inspection.</subsection><subsection number="58-17b-102(32)">"Legend drug" has the same meaning as prescription drug.</subsection><subsection number="58-17b-102(33)">"Licensed pharmacy technician" means an individual licensed with the division, that may, under the supervision of a pharmacist, perform the activities involved in the technician practice of pharmacy.</subsection><subsection number="58-17b-102(34)">"Manufacturer" means a person or business physically located in Utah licensed to be engaged in the manufacturing of drugs or devices.</subsection><subsection number="58-17b-102(35)"><subsection number="58-17b-102(35)(a)">"Manufacturing" means:<subsection number="58-17b-102(35)(a)(i)">the production, preparation, propagation, conversion, or processing of a drug or device, either directly or indirectly, by extraction from substances of natural origin or independently by means of chemical or biological synthesis, or by a combination of extraction and chemical synthesis, and includes any packaging or repackaging of the substance or labeling or relabeling of its container; and</subsection><subsection number="58-17b-102(35)(a)(ii)">the promotion and marketing of such drugs or devices.</subsection></subsection><subsection number="58-17b-102(35)(b)">"Manufacturing" includes the preparation and promotion of commercially available products from bulk compounds for resale by pharmacies, practitioners, or other persons.</subsection><subsection number="58-17b-102(35)(c)">"Manufacturing" does not include the preparation or compounding of a drug by a pharmacist, pharmacy intern, or practitioner for that individual's own use or the preparation, compounding, packaging, labeling of a drug, or incident to research, teaching, or chemical analysis.</subsection></subsection><subsection number="58-17b-102(36)">"Medical order" means a lawful order of a practitioner which may include a prescription drug order.</subsection><subsection number="58-17b-102(37)">"Medication profile" or "profile" means a record system maintained as to drugs or devices prescribed for a pharmacy patient to enable a pharmacist or pharmacy intern to analyze the profile to provide pharmaceutical care.</subsection><subsection number="58-17b-102(38)">"Misbranded drug or device" means a drug or device considered misbranded under 21 U.S.C. Sec. 352 (2003).</subsection><subsection number="58-17b-102(39)"><subsection number="58-17b-102(39)(a)">"Nonprescription drug" means a drug which:<subsection number="58-17b-102(39)(a)(i)">may be sold without a prescription; and</subsection><subsection number="58-17b-102(39)(a)(ii)">is labeled for use by the consumer in accordance with federal law.</subsection></subsection><subsection number="58-17b-102(39)(b)">"Nonprescription drug" includes homeopathic remedies.</subsection></subsection><subsection number="58-17b-102(40)">"Nonresident pharmacy" means a pharmacy located outside of Utah that sells to a person in Utah.</subsection><subsection number="58-17b-102(41)">"Nuclear pharmacy" means a pharmacy providing radio-pharmaceutical service.</subsection><subsection number="58-17b-102(42)">"Out-of-state mail service pharmacy" means a pharmaceutical facility located outside the state that is licensed and in good standing in another state, that:<subsection number="58-17b-102(42)(a)">ships, mails, or delivers by any lawful means a dispensed legend drug to a patient in this state pursuant to a lawfully issued prescription;</subsection><subsection number="58-17b-102(42)(b)">provides information to a patient in this state on drugs or devices which may include, but is not limited to, advice relating to therapeutic values, potential hazards, and uses; or</subsection><subsection number="58-17b-102(42)(c)">counsels pharmacy patients residing in this state concerning adverse and therapeutic effects of drugs.</subsection></subsection><subsection number="58-17b-102(43)">"Patient counseling" means the written and oral communication by the pharmacist or pharmacy intern of information, to the patient or caregiver, in order to ensure proper use of drugs, devices, and dietary supplements.</subsection><subsection number="58-17b-102(44)">"Pharmaceutical administration facility" means a facility, agency, or institution in which:<subsection number="58-17b-102(44)(a)">prescription drugs or devices are held, stored, or are otherwise under the control of the facility or agency for administration to patients of that facility or agency;</subsection><subsection number="58-17b-102(44)(b)">prescription drugs are dispensed to the facility or agency by a licensed pharmacist or pharmacy intern with whom the facility has established a prescription drug supervising relationship under which the pharmacist or pharmacy intern provides counseling to the facility or agency staff as required, and oversees drug control, accounting, and destruction; and</subsection><subsection number="58-17b-102(44)(c)">prescription drugs are professionally administered in accordance with the order of a practitioner by an employee or agent of the facility or agency.</subsection></subsection><subsection number="58-17b-102(45)"><subsection number="58-17b-102(45)(a)">"Pharmaceutical care" means carrying out the following in collaboration with a prescribing practitioner, and in accordance with division rule:<subsection number="58-17b-102(45)(a)(i)">designing, implementing, and monitoring a therapeutic drug plan intended to achieve favorable outcomes related to a specific patient for the purpose of curing or preventing the patient's disease;</subsection><subsection number="58-17b-102(45)(a)(ii)">eliminating or reducing a patient's symptoms; or</subsection><subsection number="58-17b-102(45)(a)(iii)">arresting or slowing a disease process.</subsection></subsection><subsection number="58-17b-102(45)(b)">"Pharmaceutical care" does not include prescribing of drugs without consent of a prescribing practitioner.</subsection></subsection><subsection number="58-17b-102(46)">"Pharmaceutical facility" means a business engaged in the dispensing, delivering, distributing, manufacturing, or wholesaling of prescription drugs or devices within or into this state.</subsection><subsection number="58-17b-102(47)"><subsection number="58-17b-102(47)(a)">"Pharmaceutical wholesaler or distributor" means a pharmaceutical facility engaged in the business of wholesale vending or selling of a prescription drug or device to other than a consumer or user of the prescription drug or device that the pharmaceutical facility has not produced, manufactured, compounded, or dispensed.</subsection><subsection number="58-17b-102(47)(b)">"Pharmaceutical wholesaler or distributor" does not include a pharmaceutical facility carrying out the following business activities:<subsection number="58-17b-102(47)(b)(i)">intracompany sales;</subsection><subsection number="58-17b-102(47)(b)(ii)">the sale, purchase, or trade of a prescription drug or device, or an offer to sell, purchase, or trade a prescription drug or device, if the activity is carried out between one or more of the following entities under common ownership or common administrative control, as defined by division rule:<subsection number="58-17b-102(47)(b)(ii)(A)">hospitals;</subsection><subsection number="58-17b-102(47)(b)(ii)(B)">pharmacies;</subsection><subsection number="58-17b-102(47)(b)(ii)(C)">chain pharmacy warehouses, as defined by division rule; or</subsection><subsection number="58-17b-102(47)(b)(ii)(D)">other health care entities, as defined by division rule;</subsection></subsection><subsection number="58-17b-102(47)(b)(iii)">the sale, purchase, or trade of a prescription drug or device, or an offer to sell, purchase, or trade a prescription drug or device, for emergency medical reasons, including supplying another pharmaceutical facility with a limited quantity of a drug, if:<subsection number="58-17b-102(47)(b)(iii)(A)">the facility is unable to obtain the drug through a normal distribution channel in sufficient time to eliminate the risk of harm to a patient that would result from a delay in obtaining the drug; and</subsection><subsection number="58-17b-102(47)(b)(iii)(B)">the quantity of the drug does not exceed an amount reasonably required for immediate dispensing to eliminate the risk of harm;</subsection></subsection><subsection number="58-17b-102(47)(b)(iv)">the distribution of a prescription drug or device as a sample by representatives of a manufacturer; and</subsection><subsection number="58-17b-102(47)(b)(v)">the distribution of prescription drugs, if:<subsection number="58-17b-102(47)(b)(v)(A)">the facility's total distribution-related sales of prescription drugs does not exceed 5% of the facility's total prescription drug sales; and</subsection><subsection number="58-17b-102(47)(b)(v)(B)">the distribution otherwise complies with 21 C.F.R. Sec. 1307.11.</subsection></subsection></subsection></subsection><subsection number="58-17b-102(48)">"Pharmacist" means an individual licensed by this state to engage in the practice of pharmacy.</subsection><subsection number="58-17b-102(49)">"Pharmacist-in-charge" means a pharmacist currently licensed in good standing who accepts responsibility for the operation of a pharmacy in conformance with all laws and rules pertinent to the practice of pharmacy and the distribution of drugs, and who is personally in full and actual charge of the pharmacy and all personnel.</subsection><subsection number="58-17b-102(50)">"Pharmacist preceptor" means a licensed pharmacist in good standing with one or more years of licensed experience.  The preceptor serves as a teacher, example of professional conduct, and supervisor of interns in the professional practice of pharmacy.</subsection><subsection number="58-17b-102(51)">"Pharmacy" means any place where:<subsection number="58-17b-102(51)(a)">drugs are dispensed;</subsection><subsection number="58-17b-102(51)(b)">pharmaceutical care is provided;</subsection><subsection number="58-17b-102(51)(c)">drugs are processed or handled for eventual use by a patient; or</subsection><subsection number="58-17b-102(51)(d)">drugs are used for the purpose of analysis or research.</subsection></subsection><subsection number="58-17b-102(52)">"Pharmacy benefits manager or coordinator" means a person or entity that provides a pharmacy benefits management service as defined in Section <xref depth="3" refnumber="31A-46-102">31A-46-102</xref> on behalf of a self-insured employer, insurance company, health maintenance organization, or other plan sponsor, as defined by rule.</subsection><subsection number="58-17b-102(53)">"Pharmacy intern" means an individual licensed by this state to engage in practice as a pharmacy intern.</subsection><subsection number="58-17b-102(54)">"Pharmacy manager" means:<subsection number="58-17b-102(54)(a)">a pharmacist-in-charge;</subsection><subsection number="58-17b-102(54)(b)">a licensed pharmacist designated by a licensed pharmacy to consult on the pharmacy's administration;</subsection><subsection number="58-17b-102(54)(c)">an individual who manages the facility in which a licensed pharmacy is located;</subsection><subsection number="58-17b-102(54)(d)">an individual who oversees the operations of a licensed pharmacy;</subsection><subsection number="58-17b-102(54)(e)">an immediate supervisor of an individual described in Subsections <xref depth="4" refnumber="58-17b-102(54)(a)">(54)(a)</xref> through <xref depth="4" refnumber="58-17b-102(d)">(d)</xref>; or</subsection><subsection number="58-17b-102(54)(f)">another operations or site manager of a licensed pharmacy.</subsection></subsection><subsection number="58-17b-102(55)">"Pharmacy technician training program" means an approved technician training program providing education for pharmacy technicians.</subsection><subsection number="58-17b-102(56)"><subsection number="58-17b-102(56)(a)">"Practice as a dispensing medical practitioner" means the practice of pharmacy, specifically relating to the dispensing of a prescription drug in accordance with Part 8, Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy, and division rule adopted after consultation with the Board of pharmacy and the governing boards of the practitioners described in Subsection <xref depth="4" refnumber="58-17b-102(23)(a)">(23)(a)</xref>.</subsection><subsection number="58-17b-102(56)(b)">"Practice as a dispensing medical practitioner" does not include:<subsection number="58-17b-102(56)(b)(i)">using a vending type of dispenser as defined by the division by administrative rule; or</subsection><subsection number="58-17b-102(56)(b)(ii)">except as permitted by Section <xref depth="3" refnumber="58-17b-805">58-17b-805</xref>, dispensing of a controlled substance as defined in Section <xref depth="3" refnumber="58-37-101">58-37-101</xref>.</subsection></subsection></subsection><subsection number="58-17b-102(57)">"Practice as a licensed pharmacy technician" means engaging in practice as a pharmacy technician under the general supervision of a licensed pharmacist and in accordance with a scope of practice defined by division rule made in collaboration with the board.</subsection><subsection number="58-17b-102(58)">"Practice of pharmacy" includes the following:<subsection number="58-17b-102(58)(a)">providing pharmaceutical care;</subsection><subsection number="58-17b-102(58)(b)">collaborative pharmacy practice in accordance with a collaborative pharmacy practice agreement;</subsection><subsection number="58-17b-102(58)(c)">compounding, packaging, labeling, dispensing, administering, and the coincident distribution of prescription drugs or devices, provided that the administration of a prescription drug or device is:<subsection number="58-17b-102(58)(c)(i)">pursuant to a lawful order of a practitioner when one is required by law; and</subsection><subsection number="58-17b-102(58)(c)(ii)">in accordance with written guidelines or protocols:<subsection number="58-17b-102(58)(c)(ii)(A)">established by the licensed facility in which the prescription drug or device is to be administered on an inpatient basis; or</subsection><subsection number="58-17b-102(58)(c)(ii)(B)">approved by the division, in collaboration with the board and, when appropriate, the Medical Licensing Board, created in Section <xref depth="3" refnumber="58-67-201">58-67-201</xref>, if the prescription drug or device is to be administered on an outpatient basis solely by a licensed pharmacist;</subsection></subsection></subsection><subsection number="58-17b-102(58)(d)">participating in drug utilization review;</subsection><subsection number="58-17b-102(58)(e)">ensuring proper and safe storage of drugs and devices;</subsection><subsection number="58-17b-102(58)(f)">maintaining records of drugs and devices in accordance with state and federal law and the standards and ethics of the profession;</subsection><subsection number="58-17b-102(58)(g)">providing information on drugs or devices, which may include advice relating to therapeutic values, potential hazards, and uses;</subsection><subsection number="58-17b-102(58)(h)">providing drug product equivalents;</subsection><subsection number="58-17b-102(58)(i)">supervising pharmacist's supportive personnel, pharmacy interns, and pharmacy technicians;</subsection><subsection number="58-17b-102(58)(j)">providing patient counseling, including adverse and therapeutic effects of drugs;</subsection><subsection number="58-17b-102(58)(k)">providing emergency refills as defined by rule;</subsection><subsection number="58-17b-102(58)(l)">telepharmacy;</subsection><subsection number="58-17b-102(58)(m)">formulary management intervention;</subsection><subsection number="58-17b-102(58)(n)">prescribing and dispensing a self-administered hormonal contraceptive in accordance with Title 26B, Chapter 4, Part 5, Treatment Access; and</subsection><subsection number="58-17b-102(58)(o)">issuing a prescription in accordance with Section <xref depth="3" refnumber="58-17b-610.8">58-17b-610.8</xref> or <xref depth="3" refnumber="58-17b-627">58-17b-627</xref>.</subsection></subsection><subsection number="58-17b-102(59)">"Practice of telepharmacy" means the practice of pharmacy through the use of telecommunications and information technologies.</subsection><subsection number="58-17b-102(60)">"Practice of telepharmacy across state lines" means the practice of pharmacy through the use of telecommunications and information technologies that occurs when the patient is physically located within one jurisdiction and the pharmacist is located in another jurisdiction.</subsection><subsection number="58-17b-102(61)">"Practitioner" means an individual currently licensed, registered, or otherwise authorized by the appropriate jurisdiction to prescribe and administer drugs in the course of professional practice.</subsection><subsection number="58-17b-102(62)">"Prescribe" means to issue a prescription:<subsection number="58-17b-102(62)(a)">orally or in writing; or</subsection><subsection number="58-17b-102(62)(b)">by telephone, facsimile transmission, computer, or other electronic means of communication as defined by division rule.</subsection></subsection><subsection number="58-17b-102(63)">"Prescription" means an order issued:<subsection number="58-17b-102(63)(a)">by a licensed practitioner in the course of that practitioner's professional practice or by collaborative pharmacy practice agreement; and</subsection><subsection number="58-17b-102(63)(b)">for a controlled substance or other prescription drug or device for use by a patient or an animal.</subsection></subsection><subsection number="58-17b-102(64)">"Prescription device" means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, and any component part or accessory, which is required under federal or state law to be prescribed by a practitioner and dispensed by or through a person or entity licensed under this chapter or exempt from licensure under this chapter.</subsection><subsection number="58-17b-102(65)">"Prescription drug" means a drug that is required by federal or state law or rule to be dispensed only by prescription or is restricted to administration only by practitioners.</subsection><subsection number="58-17b-102(66)">"Repackage":<subsection number="58-17b-102(66)(a)">means changing the container, wrapper, or labeling to further the distribution of a prescription drug; and</subsection><subsection number="58-17b-102(66)(b)">does not include:<subsection number="58-17b-102(66)(b)(i)">Subsection <xref depth="4" refnumber="58-17b-102(66)(a)">(66)(a)</xref> when completed by the pharmacist responsible for dispensing the product to a patient; or</subsection><subsection number="58-17b-102(66)(b)(ii)">changing or altering a label as necessary for a dispensing practitioner under Part 8, Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy, for dispensing a product to a patient.</subsection></subsection></subsection><subsection number="58-17b-102(67)">"Research using pharmaceuticals" means research:<subsection number="58-17b-102(67)(a)">conducted in a research facility, as defined by division rule, that is associated with a university or college in the state accredited by the Northwest Commission on Colleges and Universities;</subsection><subsection number="58-17b-102(67)(b)">requiring the use of a controlled substance, prescription drug, or prescription device;</subsection><subsection number="58-17b-102(67)(c)">that uses the controlled substance, prescription drug, or prescription device in accordance with standard research protocols and techniques, including, if required, those approved by an institutional review committee; and</subsection><subsection number="58-17b-102(67)(d)">that includes any documentation required for the conduct of the research and the handling of the controlled substance, prescription drug, or prescription device.</subsection></subsection><subsection number="58-17b-102(68)">"Retail pharmacy" means a pharmaceutical facility dispensing prescription drugs and devices to the general public.</subsection><subsection number="58-17b-102(69)"><subsection number="58-17b-102(69)(a)">"Self-administered hormonal contraceptive" means a self-administered hormonal contraceptive that is approved by the United States Food and Drug Administration to prevent pregnancy.</subsection><subsection number="58-17b-102(69)(b)">"Self-administered hormonal contraceptive" includes an oral hormonal contraceptive, a hormonal vaginal ring, and a hormonal contraceptive patch.</subsection><subsection number="58-17b-102(69)(c)">"Self-administered hormonal contraceptive" does not include any drug intended to induce an abortion, as that term is defined in Section <xref depth="3" refnumber="76-7-301">76-7-301</xref>.</subsection></subsection><subsection number="58-17b-102(70)">"Self-audit" means an internal evaluation of a pharmacy to determine compliance with this chapter.</subsection><subsection number="58-17b-102(71)">"Supervising pharmacist" means a pharmacist who is overseeing the operation of the pharmacy during a given day or shift.</subsection><subsection number="58-17b-102(72)">"Supportive personnel" means unlicensed individuals who:<subsection number="58-17b-102(72)(a)">may assist a pharmacist, pharmacist preceptor, pharmacy intern, or licensed pharmacy technician in nonjudgmental duties not included in the definition of the practice of pharmacy, practice of a pharmacy intern, or practice of a licensed pharmacy technician, and as those duties may be further defined by division rule adopted in collaboration with the board; and</subsection><subsection number="58-17b-102(72)(b)">are supervised by a pharmacist in accordance with rules adopted by the division in collaboration with the board.</subsection></subsection><subsection number="58-17b-102(73)">"Unlawful conduct" means the same as that term is defined in Sections <xref depth="3" refnumber="58-1-501">58-1-501</xref> and <xref depth="3" refnumber="58-17b-501">58-17b-501</xref>.</subsection><subsection number="58-17b-102(74)">"Unprofessional conduct" means the same as that term is defined in Sections <xref depth="3" refnumber="58-1-501">58-1-501</xref> and <xref depth="3" refnumber="58-17b-502">58-17b-502</xref> and may be further defined by rule.</subsection><subsection number="58-17b-102(75)">"Veterinary pharmaceutical facility" means a pharmaceutical facility that dispenses drugs intended for use by animals or for sale to veterinarians for the administration for animals.</subsection><subsection number="58-17b-102(76)">"Written communication" means a physical document, or an electronic communication, by or from which the recipient may read or access the information intended to be communicated, including:<subsection number="58-17b-102(76)(a)">email;</subsection><subsection number="58-17b-102(76)(b)">text message; and</subsection><subsection number="58-17b-102(76)(c)">quick response (QR) code.</subsection></subsection></section>